Research
Hormonal
Insulin resistance compromises the body's normal response to insulin, leading to multiple diseases including Type 2 diabetes mellitus.
Practitioners should recognize insulin resistance as a critical factor in managing metabolic diseases.
StrongSupportsmedium confidence
Insulin resistance is the biological phenomenon in which the human body's normal response to the metabolic hormone insulin is compromised.
Why this rating
The abstract summarizes a review of established knowledge.
Source
Insulin Resistance: An Update on Biochemical and Pathophysiological Mechanisms and Impact on Various Diseases
Peter J. Little et al. · iNew Medicine · 2026
DOI 10.1002/inm3.70028
review
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →